Application Nr Approved Date Route Status External Links
NDA021585 None Oral None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Active Ingredients (In Each Extended-Release Tablet) Purposes Guaifenesin 600 Mg Expectorant Pseudoephedrine Hcl 60 Mg Nasal Decongestant

All Formulated Excipients (0 Total)

None

Active Ingredients ( 2 Total)

Name Structure ZINC ID(s)
1. Guaifenesin GUAIFENESIN ZINC394284
2. Pseudoephedrine Hydrochloride PSEUDOEPHEDRINE HYDROCHLORIDE ZINC20259

Comments